Job · New York, NY

R&D Engineer II

Chan Zuckerberg Biohub · Medical Research · $99.6M budget · 167 staff · Since 2016

Conducting cutting-edge medical research to advance healthcare.

Before you apply

FY2024 · Form 990Independent: from IRS data, not the org
Pays its leaders
$303K–$904K
11 officers reported
Fine: from the org's Form 990.
Pt VII · Sec A
Budget
$142.4M
spent in FY2024
Fine: from the org's Form 990.
Pt I · Ln 18
Staff
167
employees
Fine: from the org's Form 990.
Pt I · Ln 5–6
Spent on programs
85%
of spending
Looks good: 85% of spending went to programs; 75% or more.
Pt IX · Ln 25 · col B
Surplus or deficit
−43%
of revenue, FY2024
Concern: revenue was below expenses in the latest filing.
Pt I · Ln 19
Cash reserves
117 mo
of spending, in cash and securities
Looks good: 117.4 months of spending in cash; 3 or more.
Pt X · Ln 1–2 · Pt I · Ln 18
Latest return
FY2024
latest Form 990
Looks good: the latest return is for FY2024, 2 tax years back; within 2 tax years.
IRS e-file
IRS status
501(c)(3)
tax-exempt since 2016
Looks good: listed by the IRS.
IRS BMF
Looks goodFineWorth a lookConcernTap a box for the reason.

About the role

The org's own posting, as written

Biohub is the first large-scale initiative bringing frontier AI models, massive compute, and frontier experimental capabilities under one roof. We're building a general-purpose system to accelerate scientific discovery, integrating frontier AI models, biological foundation models, and lab capabilities, with the ultimate goal of curing disease. Our technology powers scientists around the world, translating AI capabilities into tools that accelerate research everywhere.

The Team Our immune cell reprogramming team integrates foundational research on immunology and disease biology with AI-modeling to develop engineered cells that harness our own immune system to detect and treat early signs of age-related diseases, like cancer, Alzheimer’s, and Parkinson’s. These technologies will enable precise, context-dependent therapeutic responses only when and where it is needed. You can learn more about our work here . Our work brings together three powerhouse universities - Columbia University, The Rockefeller University, and Yale University - into a single collaborative technology and discovery engine.

Our Vision Pursue large scientific challenges that cannot be pursued in conventional environments Enable individual investigators to pursue their riskiest and most innovative ideas Facilitate research by scientists and clinicians at our home institutions and beyond We are a team of passionate individuals powered by technology, guided by scientific research, and driven by collaboration, working toward a mission to cure or prevent all disease.

The Opportunity

The Advanced Single Cell Technologies group provides critical single cell profiling and perturbation assays, technology, and expertise to the Biohub NY community. The goal of the platform is to develop cutting-edge single-cell technologies in collaborations related to studying human disease and the interaction of immune cells with human organs. More information can be found on the lab website ( https://biohub.org/single-cell-technology-platform/) . The R&D Engineer II will create new technologies and devices for high throughput single-cell screening and will have demonstrated experience in designing, prototyping, testing and troubleshooting diagnostic or point-of-care medical devices.

We are seeking a creative, methodical, resourceful, and technically rigorous engineer capable of driving projects independently and on a team. This role sits at the intersection of device engineering, cell biology/immunology, and reagent formulation, and requires an ability to own a problem end-to-end, from proof-of-concept demonstration to prototype and beyond. This role offers substantial design freedom with direct lab access for rapid testing.

What You'll Do

Design, build and test prototypes for point-of-care sample processing, iterating based on performance data and optimizing for reproducibility Design mechanisms for controlled timing and sequencing of biochemical processes within a device (e.g., controlled reagent…

Read the full posting

About Chan Zuckerberg Biohub

From its Form 990

More like this